UnitedHealth Stock Analysis: Investment Committee Member Doubling Down

UnitedHealth's Current Performance and Investment

• 📉 UnitedHealth is currently accounting for the majority of the Dow's losses, with the stock down 22%.
• 📈 Despite the downturn, one Investment Committee member, Steve Weiss, has bought more stock this morning, even at a slightly higher price.
• 💡 Weiss is currently down slightly on the position but sees it as a good long-term investment.

Navigating a Tough Environment

• ⚠️ The narrative last year suggested peak usage for healthcare services, but usage is actually peaking now, potentially extending further.
• 💰 This increased usage is partly due to higher premiums on large plans, leading employees to utilize their benefits more.
• 🎯 The transition to value-based care, especially for seniors, is driving wellness exams and upfront costs, which is expected to improve MLR (Medical Loss Ratio) going forward.

Regulatory and Valuation Insights

• 🏥 UnitedHealth is highlighted as a company adept at navigating these complex issues.
• 📊 The Biden administration's impact on typical rate increases is noted, with only a ~2% increase this year.
• 📈 For next year, the rate increase is over 5%, exceeding expectations of 4%, which drove the stock last week.
• 💰 With the stock trading at 17 times earnings and down 12% in guidance despite being a critical company, Weiss believes the valuation is excellent and the market's reaction doesn't add up.